Anondita Medicare Limited increased its stake in Anondita Medi from 61.83% to 61.97% by purchasing 26,000 shares for ₹1.81 Cr at ₹695.27 apiece on March 18, 2026.
A personal care manufacturer specializing in flavored male contraceptive products, Anondita Medi produces condoms under its flagship COBRA brand. Founded in 2024, the company operates in the niche segment of flavored contraceptives within India's broader sexual wellness and personal care market. Its distinctive approach targets evolving consumer preferences for enhanced intimate experiences through innovative product formulation, design, and strategic branding in the contraceptive category.
Get the next move the moment it happens.
Follow the investors and Anondita Medi. on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
